Co-Scientist unites Boston Children’s Hospital and MIT’s labs to explore new RNA-based treatments for ALS.
ذكاء اصطناعي يقود ثورة في علاج التصلب الجانبي
Google DeepMind and partners from Boston Children’s Hospital and MIT are collaborating to develop RNA-based therapies for amyotrophic lateral sclerosis (ALS). This initiative integrates AI-driven biological modeling with experimental lab work to accelerate therapeutic discovery. The approach represents a convergence of computational biology and clinical neuroscience.
AI
ملخص الذكاء الاصطناعي
- Google DeepMind and partners from Boston Children’s Hospital and MIT are collaborating to develop RNA-based therapies for amyotrophic lateral sclerosis (ALS). This initiative integrates AI-driven biological modeling with experimental lab work to accelerate therapeutic discovery. The approach represents a convergence of computational biology and clinical neuroscience.
- هذا التعاون يمثل نقلة نوعية في توظيف الذكاء الاصطناعي ليس فقط للتنبؤ، بل لتصميم علاجات جزيئية مُخصصة لأمراض عصبية معقدة لم تجد حلولًا فعالة منذ عقود.
- Co-Scientist unites Boston Children’s Hospital and MIT’s labs to explore new RNA-based treatments for ALS.
المصدر الأصلي:
Google DeepMind Blog
